T1	Outcomes 877 945	using efficacy results from the EEC, IgG responses, and tolerability
T2	Outcomes 1013 1014	.
T3	Outcomes 1015 1038	The total symptom score
T4	Outcomes 1253 1261	320 Î¼g)
T5	Outcomes 1356 1395	were well tolerated, no serious adverse
T6	Outcomes 1402 1434	occurred; two Grade II reactions
